| Li YC |
------>authors3_c=None ------>paper_class1=1 ------>Impact_Factor=None ------>paper_class3=2 ------>paper_class2=4 ------>vol=91 ------>confirm_bywho=jack ------>insert_bywho=701056 ------>Jurnal_Rank=None ------>authors4_c=None ------>comm_author=1 ------>patent_EDate=None ------>authors5_c=None ------>publish_day=None ------>paper_class2Letter=None ------>page2=379 ------>medlineContent= ------>unit=E0700 ------>insert_date=20050824 ------>iam=2 ------>update_date=None ------>author=??? ------>change_event=4 ------>ISSN=None ------>authors_c=None ------>score=-74 ------>journal_name=Br J Surg ------>paper_name=Using information technology to improve surgical safety ------>confirm_date=20051207 ------>tch_id=090090 ------>pmid=19722742 ------>page1=379 ------>fullAbstract=CONTEXT: The Joint Commission and the College of American Pathologists have emphasized improved communication as a strategy to improve patient safety and reduce errors. OBJECTIVE: To determine current policies and practices concerning critical and/or significant and unexpected results in anatomic pathology. DESIGN: A survey was distributed with the 2007 D mailing of the Performance Improvement Program slides. The survey included questions that determined laboratory size, practice setting, and anatomic pathology critical and/or significant and unexpected result policies and practices. RESULTS: Surveys from 1130 laboratories were received. A total of 75% had a written policy regarding anatomic pathology critical and/or significant and unexpected results; 25% did not. A total of 30% of laboratories with written policies stated that their policies included guidelines but did not include specific examples. A total of 33% listed 5 or fewer specific examples, 18% listed more than 5 examples, and 19% stated that they had a specifically defined list of significant and unexpected and/or critical diagnoses. The conditions that were listed included malignancies (48% of all laboratories), findings not expected by the clinical history (45%), life-threatening infections (45%), no chorionic villi in products of conception (37%), inflammatory or immunologic processes (19%), and organ rejection (14%). Laboratories with a higher median number of accessioned surgical and cytology cases and independent laboratories tended to have policies with more than 5 specific examples or precise lists of must-call diagnoses (P < .001). CONCLUSIONS: This survey illustrates current anatomic pathology policies and practices with respect to critical and significant and unexpected results. ------>tmu_sno=None ------>sno=11670 ------>authors2=Hsu MH ------>authors3= ------>authors4= ------>authors5= ------>authors6= ------>authors6_c=None ------>authors=Li YC ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c=None ------>publish_area=None ------>updateTitle=Significant and unexpected, and critical diagnoses in surgical pathology: a College of American Pathologists~ survey of 1130 laboratories. ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no=8 ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2005 ------>submit_flag=None ------>publish_month=None |